ALDURAZYME
NDC 58468-0070, laronidase, injection, solution, concentrate, from Genzyme Corporation.
- Product NDC
- 58468-0070
- Status
- Listed
- Labeler
- Genzyme Corporation
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125058
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LARONIDASE2.9 mg/5mL
Pharmacologic classes
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]; alpha-Glucosidases [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58468-0070-1 | 58468007001 | 5 mL in 1 VIAL, GLASS (58468-0070-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a80ac249-cae4-41f3-88bb-344088b20e60Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=58468-0070
Use it
Look up 58468-0070 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58468-0070. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.